Alimera Sciences (NASDAQ:ALIM) Research Coverage Started at StockNews.com
StockNews.com started coverage on shares of Alimera Sciences (NASDAQ:ALIM – Free Report) in a research report released on Wednesday. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reiterated a buy rating and issued a $5.00 target price on shares of Alimera Sciences in a report on Monday, August 14th. […]